Loading...
•
Sep 30, 2024
Alphatec Q3 2024 Earnings Report
Reported third quarter results with revenue growth and increased full-year guidance.
Key Takeaways
Alphatec Holdings, Inc. announced strong financial results for the third quarter of 2024, with total revenue reaching $151 million, a 27% increase year-over-year. The company raised its full-year revenue guidance to $605 million and expects non-GAAP adjusted EBITDA of approximately $27 million.
Surgical revenue grew by 30%, while total revenue increased by 27%.
GAAP gross margin was reported at 68%, and non-GAAP gross margin at 69%.
The company achieved 19% growth in new surgeon adoption.
Free cash use was reduced to $21 million as the accelerated investment phase nears completion.
Revenue by Segment
Forward Guidance
For the full year 2024, the company expects total revenue to grow 25% to $605 million, including surgical revenue of $540 million and EOS revenue of $65 million. Non-GAAP adjusted EBITDA is expected to be approximately $27 million.
Positive Outlook
- Total revenue is expected to grow 25% to $605 million.
- Surgical revenue is projected to be $540 million.
- EOS revenue is anticipated to reach $65 million.
- Non-GAAP adjusted EBITDA is expected to be approximately $27 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...